EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis

Tingting Yang1, Chanping You2, Shuhui Meng3

  • 1Department of Pharmacy, Shenzhen University General Hospital, Shenzhen, China.

Insights

Epstein-Barr virus (EBV) infection reprograms host cell metabolism via viral oncogenes like LMP1/2 and miR-BARTs. This metabolic shift fuels nasopharyngeal carcinoma (NPC) development, offering potential therapeutic targets for EBV-associated cancers.

Area of Science:

  • Molecular biology
  • Oncology
  • Virology
  • Metabolic pathways

Background:

  • Viral oncogenes can induce cellular metabolic reprogramming, crucial for malignant transformation.
  • Epstein-Barr virus (EBV) infection, particularly latent EBV, is linked to nasopharyngeal carcinoma (NPC).
  • Key EBV oncoproteins, including latent membrane proteins 1 and 2 (LMP1/2) and EBV-encoded BamH I-A rightward transcripts (BART) microRNAs (miR-BARTs), are implicated in altering host cell metabolism.

Purpose of the Study:

  • To elucidate the mechanisms by which EBV infection and its oncogenes mediate metabolic reprogramming in host cells.
  • To understand the role of EBV-induced metabolic alterations in the pathogenesis of nasopharyngeal carcinoma (NPC).
  • To explore potential therapeutic strategies targeting metabolic pathways in EBV-associated malignancies.

Main Methods:

  • Review of existing literature on EBV, oncogenes, and cellular metabolism.
  • Analysis of signaling transduction pathways dysregulated by viral oncogenes.
  • Focus on metabolic shifts induced by EBV oncoproteins (LMP1/2, miR-BARTs) in NPC pathogenesis.

Main Results:

  • EBV infection significantly alters host cell metabolism through its oncogenes.
  • Specific viral oncoproteins (LMP1/2, miR-BARTs) play critical roles in driving these metabolic changes.
  • Metabolic reprogramming supports the malignant transformation and progression of NPC.

Conclusions:

  • EBV-driven metabolic reprogramming is a key factor in NPC development.
  • Understanding these metabolic alterations provides insights into virus-associated cancer pathogenesis.
  • Targeting EBV-induced metabolic pathways presents a promising therapeutic avenue for EBV-associated cancers.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K